XPH : SPDR S&P Pharmaceuticals ETF

XPH is a Sector Equity Market Healthcare with LOW fees.

XPH

SPDR S&P Pharmaceuticals ETF

FI Score

59 /100

Diversification Rating

10 /10

Expense Ratio Rating

9 /10

Expense Rating

7 /10

Market Score

3 /10

Category Score

0 /10

Market Size

3 /10

59% FI Score
  • xph
  • ETF
  • Sector Equity
  • Healthcare

SPDR S&P Pharmaceuticals ETF

Expenses: 0.35% (Better than 1% of similar funds)

This is an OK choice for a Healthcare Sector Equity fund. See why ยป

Fund Summary

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). The fund is non-diversified.

Largest Holdings

Amount Holding
7.04% Horizon Therapeutics Public Limited Company
6.28% Catalent, Inc
5.88% Eli Lilly and Company
5.23% Zoetis Inc
4.92% Johnson & Johnson
4.77% Nektar Therapeutics
4.74% Perrigo Company plc
4.66% Pfizer Inc
4.37% Bristol-Myers Squibb Company
4.23% Merck & Co., Inc

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2022   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo